| abstract |
(57) [Summary]nThe present invention thus relates to the field of physiotherapy medicine. Specifically, the present invention relates to the discovery that factors that inhibit the binding of cortisol to its receptor can be used in methods for treating mild cognitive impairment. Mifepristone, a potential specific glucocorticoid receptor antagonist, can be used in these methods. The present invention also provides a kit for treating mild cognitive impairment in a human, comprising a glucocorticoid receptor antagonist and instructional materials teaching the administration, dosage and schedule of the glucocorticoid receptor antagonist. . |